Leptin Signaling in Lean and Obese Humans
Withdrawn before enrolling
Conditions studied: Obesity
In brief
Obesity does not respond to high circulating levels of the hormone leptin. This study is aiming at finding out why this happens and open new avenues for treatment of obesity.
Key facts
- Study ID
- NCT01297426
- Run by
- VA Office of Research and Development
- People needed
- 0
- Starts
- 2011-04-01
- Expected to finish
- 2015-06-01
- Last updated by the study team
- 2015-12-24
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- men and women
- ages 18 to 65
- BMI ranges between 20 and 45 kg/m2
You may not qualify if…
- subjects requiring special diets
- history of illness other than obesity of diabetes
- taking medications known to influence glucose metabolism
- subjects with history of anaphylactic reaction or hypersensitivity to e. coli derived proteins or anesthetic agents
- women who are breastfeeding, pregnant or wanting to become pregnant
- subjects with bleeding dyscrasia or poor wound healing
Where it is running
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.